Identifikatu
Taldeak
Ikertzaileak
Emaitzak
HOSPITAL UNIVERSITARIO RUBER
Saila
Université Catholique de Louvain
Louvain-la-Neuve, Bélgica
Hemen zaude
Lankidetzak
Université Catholique de Louvain
Université Catholique de Louvain-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2022
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial
Journal of Clinical Oncology, Vol. 32
2017
Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Oncology, Vol. 18, Núm. 7, pp. 904-916
Kontaktua
Lege-oharra
Laguntza
translate
eu
arrow_drop_down
translate
eu
arrow_drop_down
es
ca
gl
en
fr
de